Sunil Yeruva1, Giuliano Ramadori, Dirk Raddatz. 1. Centre for Internal Medicine, Department of Gastroenterology and Endocrinology, University of Göttingen, Goettingen, Germany.
Abstract
BACKGROUND AND AIMS: Little is known about the intestinal epithelial expression and secretion of CXCL10 (IP-10), a chemokine involved in recruiting T cells and monocytes. We aimed to study CXCL10 gene expression and regulation by the pro-inflammatory cytokines interleukin (IL)-1beta, interferon (IFN)-gamma and tumour necrosis factor (TNF)-alpha in intestinal epithelial cell lines. MATERIALS AND METHODS: CXCL10 expression and secretion kinetics were assessed in Caco-2, HT-29 and DLD1 human colon epithelial cells, treated with IL-1beta, TNF-alpha, IFN-gamma alone or in combination with each other by real-time polymerase chain reaction (PCR), Northern blotting and enzyme-linked immunoabsorbent assay (ELISA). Transient transfections with TGL-IP10 (CXCL10 promoter) and TGL-IP10-kappaB2 mutant promoter and gelshifts and supershifts for nuclear factor (NF)-kappaB were also performed. RESULTS: Real-time PCRs and ELISA experiments revealed that IL-1beta was the strongest and earliest inducer of CXCL10 messenger ribonucleic acid (mRNA) expression and protein secretion in Caco-2 cell line, whereas INF-gamma had a delayed kinetics. There was a strong synergistic effect of either TNF-alpha or IL-1beta with IFN-gamma both on CXCL10 mRNA expression and protein secretion in all three cell lines. Real-time PCR and ELISA experiments using a specific NF-kappaB inhibitor and transfection experiments with a NF-kappaB-binding defective CXCL10 promoter construct revealed that the induction of CXCL10 by IL-1beta and its synergism with IFN-gamma is NF-kappaB dependent. CONCLUSION: These data demonstrate that in colonic epithelial cells, depending on the cellular context and utilizing the NF-kappaB pathway, IL-1beta alone and/or in synergism with IFN-gamma may play a major role in the induction of CXCL10.
BACKGROUND AND AIMS: Little is known about the intestinal epithelial expression and secretion of CXCL10 (IP-10), a chemokine involved in recruiting T cells and monocytes. We aimed to study CXCL10 gene expression and regulation by the pro-inflammatory cytokines interleukin (IL)-1beta, interferon (IFN)-gamma and tumour necrosis factor (TNF)-alpha in intestinal epithelial cell lines. MATERIALS AND METHODS:CXCL10 expression and secretion kinetics were assessed in Caco-2, HT-29 and DLD1 human colon epithelial cells, treated with IL-1beta, TNF-alpha, IFN-gamma alone or in combination with each other by real-time polymerase chain reaction (PCR), Northern blotting and enzyme-linked immunoabsorbent assay (ELISA). Transient transfections with TGL-IP10 (CXCL10 promoter) and TGL-IP10-kappaB2 mutant promoter and gelshifts and supershifts for nuclear factor (NF)-kappaB were also performed. RESULTS: Real-time PCRs and ELISA experiments revealed that IL-1beta was the strongest and earliest inducer of CXCL10 messenger ribonucleic acid (mRNA) expression and protein secretion in Caco-2 cell line, whereas INF-gamma had a delayed kinetics. There was a strong synergistic effect of either TNF-alpha or IL-1beta with IFN-gamma both on CXCL10 mRNA expression and protein secretion in all three cell lines. Real-time PCR and ELISA experiments using a specific NF-kappaB inhibitor and transfection experiments with a NF-kappaB-binding defective CXCL10 promoter construct revealed that the induction of CXCL10 by IL-1beta and its synergism with IFN-gamma is NF-kappaB dependent. CONCLUSION: These data demonstrate that in colonic epithelial cells, depending on the cellular context and utilizing the NF-kappaB pathway, IL-1beta alone and/or in synergism with IFN-gamma may play a major role in the induction of CXCL10.
Authors: D M Boorsma; J Flier; S Sampat; C Ottevanger; P de Haan; L Hooft; R Willemze; C P Tensen; T J Stoof Journal: Arch Dermatol Res Date: 1998-06 Impact factor: 3.017
Authors: M Uguccioni; P Gionchetti; D F Robbiani; F Rizzello; S Peruzzo; M Campieri; M Baggiolini Journal: Am J Pathol Date: 1999-08 Impact factor: 4.307
Authors: Adi Zipin-Roitman; Tsipi Meshel; Orit Sagi-Assif; Bruria Shalmon; Camila Avivi; Raphael M Pfeffer; Isaac P Witz; Adit Ben-Baruch Journal: Cancer Res Date: 2007-04-01 Impact factor: 12.701
Authors: S Gasperini; M Marchi; F Calzetti; C Laudanna; L Vicentini; H Olsen; M Murphy; F Liao; J Farber; M A Cassatella Journal: J Immunol Date: 1999-04-15 Impact factor: 5.422
Authors: William R Coward; Keira Watts; Carol A Feghali-Bostwick; Gisli Jenkins; Linhua Pang Journal: Mol Cell Biol Date: 2010-04-19 Impact factor: 4.272
Authors: Caitlin M Miller; Hisashi Akiyama; Luis M Agosto; Ann Emery; Chelsea R Ettinger; Ronald I Swanstrom; Andrew J Henderson; Suryaram Gummuluru Journal: J Virol Date: 2017-06-09 Impact factor: 5.103
Authors: Yoichiro Uchida; Maria Cecilia S Freitas; Danyun Zhao; Ronald W Busuttil; Jerzy W Kupiec-Weglinski Journal: Transplantation Date: 2010-05-15 Impact factor: 4.939
Authors: Jillian L Pope; Ajaz A Bhat; Ashok Sharma; Rizwan Ahmad; Moorthy Krishnan; Mary K Washington; Robert D Beauchamp; Amar B Singh; Punita Dhawan Journal: Gut Date: 2013-06-13 Impact factor: 23.059
Authors: Naresh Singh Redhu; Ali Saleh; Lianyu Shan; William T Gerthoffer; Sam K Kung; Andrew J Halayko; Bouchaib Lamkhioued; Abdelilah S Gounni Journal: PLoS One Date: 2009-07-07 Impact factor: 3.240